Target intelligence / Profile preview

Forkhead box F1-regulated DNA elements (FOXF1-REs)

Target
FOXF1-REs
Molecular classification
DNA, Regulatory element, Enhancer, Promoter
01

Overview

Forkhead box F1 (FOXF1)-regulated DNA elements are specific genomic sequences, including enhancers and promoters, that serve as binding sites for the FOXF1 transcription factor or control the expression of the FOXF1 gene itself. These elements are essential for the transcriptional regulation of genes involved in pulmonary vasculogenesis, lung septation, and mesenchymal cell proliferation (UniProt Q12946). In humans, the proper functioning of these DNA elements is critical during embryonic development, particularly for the formation of the alveolar capillary network. Deletions or point mutations in the 60 kb genomic region located approximately 250 kb upstream of the FOXF1 gene—which acts as a lung-specific enhancer—are a major cause of Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACDMPV) (PubMed 23603761). Beyond developmental disorders, FOXF1-regulated elements are implicated in the pathogenesis of various cancers, where they may be hijacked to promote epithelial-mesenchymal transition and metastasis (PubMed 27161204). While there are currently no approved small-molecule drugs that directly target these DNA elements, they are primary candidates for emerging genetic therapies, including CRISPR-mediated activation or repression and antisense oligonucleotide interventions. The therapeutic challenge lies in achieving tissue-specific modulation to avoid systemic developmental toxicity or oncogenic risks associated with misregulation of the FOXF1 pathway.

Other names
FOXF1 enhancersFOXF1 binding sitesFOXF1 response elements16q24.1 regulatory regionFOXF1 cis-regulatory elements
02

Mechanism of action

Transcription factor binding to cis-regulatory elements to recruit transcriptional co-activators and RNA polymerase II, thereby modulating the expression of genes essential for pulmonary and vascular development.

03

Biological functions

Gene expression regulationLung developmentVascular developmentOrganogenesisMesenchymal cell proliferation
04

Disease associations

Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV)Lung cancerPulmonary fibrosisGastrointestinal malformations
05

Safety considerations

Off-target genomic alterations from gene editingDevelopmental toxicity due to FOXF1 haploinsufficiencyOncogenic potential of ectopic FOXF1 expressionTissue-specific delivery challenges
06

Biomarkers

FOXF1 enhancer deletions (16q24.1)FOXF1 mRNA expression levelsSingle nucleotide polymorphisms (SNPs) in FOXF1 regulatory regions

Beyond the preview

Go deeper on Forkhead box F1-regulated DNA elements (FOXF1-REs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Forkhead box F1-regulated DNA elements (FOXF1-REs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call